My PCR
Create Account
Logo PCR

NSTEMI (Non-ST-segment elevation myocardial infarction)

Latest NSTEMI content in interventional cardiology - research, practice, and education

NSTEMI is considered one of the leading causes of morbidity and mortality and its definition and treatment remains challenging requiring specific, adapted responses. Understanding different biomarkers, becoming aware of emerging new agents used in adjunctive pharmacotherapy, keeping abreast of advances in imaging techniques as well as the use of invasive imaging and functional assessment is critical. Tools, devices and techniques, and complications such as different types of vascular access or bleeding risks, can also be found here…

Filtered By
NSTEMI

243 results

3-year outcomes of the ULTIMATE trial comparing intravascular ultrasound versus angiography-guided drug-eluting stent implantation

23 Feb 2021

ULTIMATE provides additional long-term randomised control data showing the benefit of IVUS guided PCI in an all-comers population.

Nicola Ryan

Reviewer

Nicola Ryan
ULTIMATE was a randomised control trial comparing IVUS vs DES implantation in 1,448 allcomers.

A COVID(+) patient with STEMI and prior PCI

27 May 2020

Flavio Ribichini and Thomas Cuisset discuss a case of a COVID(+) patient with STEMI and prior PCI presented by Alejandro Ricalde.

PCR on Call - A COVID(+) patient with STEMI and prior PCI

An NSTEMI case due to a severe LM calcific sub-occlusive stenosis

22 Oct 2019

View this case of an 85-year-old woman, hypertensive under medical therapy with no previous medical or surgical history, who called the emergency services about chest pain and shortness of breath...

Author

Flavio Luciano Ribichini
NSTEMI case due to a severe LM calcific sub-occlusive stenosis